Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
14 May 2015
Header
Header image
News

News

EFPIA Publishes Annual 3Rs Report
08 May 2015

EFPIA has today published its annual 3Rs report, aimed at clarifying and updating information on the use of animals in research for the development of [...] Read more

News

EFPIA Partners with Financial Times for FT Digital Health Summit Europe
13 May 2015

EFPIA is delighted to announce its official partnership with the Financial Times Digital Health Summit Europe, taking place on 10th June, in London, UK. Digital health [...] Read more

Videos

Video

Interview: Joseph Jimenez CEO Novartis & President EFPIA

Interview with Joseph Jimenez on his aspirations for his presidency and the 2015 EFPIA Annual Meetings.

View video

Events calendar

Events Calendar

Countdown - 1 week: EFPIA Annual Meetings 3-5 June 2015
From 03/06/2015 to 05/06/2015 (Luxembourg)

Only 1 week to go - Register Urgently

EFPIA will be holding its 2015 Annual Meetings from 3 to 5 June in Luxembourg. The event provides an unparalleled opportunity to discuss the key issues driving the European pharmaceutical and healthcare agenda as well as network with senior industry and European stakeholders.

PROGRAMME

REGISTRATION

 

Read more

Events Calendar

FT Digital Health Summit Europe
On 10/06/2015 (London)

The Financial Times is delighted to announce the FT Digital Health Summit Europe: Delivering Scalable and Affordable Innovations, taking place on Wednesday 10th June, in London, UK. Digital [...] Read more

Events Calendar

15 years after the Orphan Medicines Regulation, are rare disease patients getting the innovation and treatments they need?
On 26/05/2015 (Radisson Blue EU Hotel, Rue d’Idalie 35, 1050 Brussels)

Hosted by Françoise Grossetête and Mr Philippe de Backer MEPs

Building on the 15th anniversary since the adoption of the Orphan Medicines Regulation (EC 141/2000), this conference aims to illustrate the therapeutic advances made possible by the EU framework and to discuss current challenges for rare diseases patients, especially as regards access to diagnosis and treatment. A high level panel of speakers from academia, regulators, industry and patient community will discuss and explore best practices and policy options to address such issues at the EU and at the national level. 

You can download the detailed programme from here.

The report of the event can be downloaded here.

Pictures from the event are available here.

Supported by EFPIA and EuropaBio.

Presentations from the event are available here:

Kerstin Westermark: 15 years after the Orphan Medicines Regulation, are rare disease patients getting the innovation and treatments they need?

- Vinciane Pirard: The pioneering role of rare diseases in science

- Kevin Loth: THE VALUE OF MEDICAL INNOVATION Partnering to improve patient access 

Josep Torrent-Farnell: “Bridging” EU pathways for orphan medicines

 

 

Read more

Events Calendar

EFGCP Multi-Stakeholder Workshop on Communicating Clinical Trial Results to Meet Public Needs - A Meaningful Future for Lay Summaries
On 29/05/2015 (Thon Hotel EU, Brussels, Belgium)

Returning results of clinical trials to participants allows for investigators and sponsors to honor the essential contributions and voluntarism of study participants, while improving the [...] Read more

Documents

From our blog

Access to finance and barriers to growth in the innovative biopharmaceuticals sector
08 May 2015 (Reports & Studies)

Although there is a large literature on the competitiveness and growth of micro and small- and medium-sized enterprises (SMEs) in Europe,1 particularly those investing in [...] Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail